Paradice Investment Management Cuts Avanos Medical Stake to 6.1%

TL;DR

**Paradice Investment Management just trimmed its AVNS stake to 6.1%.**

AI Summary

Paradice Investment Management LLC, an investment firm, filed an amended Schedule 13G/A on February 7, 2024, disclosing its ownership in Avanos Medical, Inc. As of December 31, 2023, Paradice beneficially owned 2,499,999 shares of Avanos Medical's common stock, representing 6.1% of the company's outstanding shares. This is a decrease from their previous reported ownership, indicating they have reduced their stake. This matters to investors because a significant institutional investor reducing its position could signal a less optimistic outlook on the stock's future performance.

Why It Matters

A major institutional investor reducing its holdings can be interpreted as a lack of confidence in the company's future prospects, potentially influencing other investors' decisions and the stock price.

Risk Assessment

Risk Level: medium — The reduction in ownership by a significant institutional investor could indicate potential headwinds or a less favorable outlook for Avanos Medical, posing a moderate risk to current and prospective shareholders.

Analyst Insight

A smart investor would consider this reduction in institutional ownership as a potential bearish signal and might investigate the reasons behind Paradice Investment Management LLC's decision to reduce its stake before making any investment decisions regarding Avanos Medical, Inc.

Key Numbers

• 2,499,999 — Shares Beneficially Owned (This is the total number of Avanos Medical shares Paradice Investment Management LLC reported owning as of December 31, 2023.)
• 6.1% — Percentage of Class (This represents the portion of Avanos Medical's common stock that Paradice Investment Management LLC controls, indicating a significant but reduced stake.)
• December 31, 2023 — Reporting Date (This is the snapshot date for the ownership information, crucial for understanding the recency of the data.)

Key Players & Entities

• Paradice Investment Management LLC (company) — the reporting person who filed the SC 13G/A
• Avanos Medical, Inc. (company) — the subject company whose securities are being reported
• 2,499,999 shares (dollar_amount) — the number of shares beneficially owned by Paradice Investment Management LLC
• 6.1% (dollar_amount) — the percentage of Avanos Medical, Inc.'s class of securities beneficially owned by Paradice Investment Management LLC
• December 31, 2023 (date) — the date of the event which requires the filing of this statement
• February 7, 2024 (date) — the filing date of the SC 13G/A

Forward-Looking Statements

• Avanos Medical's stock price may experience downward pressure due to the reduced institutional ownership. (AVNS) — medium confidence, target: Q1 2024
• Other institutional investors might re-evaluate their positions in Avanos Medical following this disclosure. (Institutional Investors) — low confidence, target: Q2 2024

FAQ

Key Financial Figures

• $0.01 — nc. (Name of Issuer) Common Stock - $0.01 Par Value (Title of Class of Securiti

Filing Documents

• paradice-avns123123a3.htm (SC 13G/A) — 76KB
• 0001172661-24-000525.txt ( ) — 78KB

(a)Name of Issuer

Item 1. (a)Name of Issuer Avanos Medical, Inc. (b)Address of Issuer’s Principal Executive Offices 5405 Windward Parkway, Suite 100 South Alpharetta, Georgia 30004

(a)Name of Person Filing

Item 2. (a)Name of Person Filing Paradice Investment Management LLC Paradice Investment Management Pty Ltd (b)Address of Principal Business Office, or, if none, Residence Paradice Investment Management LLC 250 Fillmore St, Suite 425 Denver, Colorado 80206 Paradice Investment Management Pty Ltd Level 27 The Chifley Tower 2 Chifley Square Sydney NSW 2000 Australia (c)Citizenship Paradice Investment Management LLC - Delaware Paradice Investment Management Pty Ltd - Australia (d)Title of Class of Securities Common Stock - $0.01 Par Value (the “Common Stock”) (e) CUSIP No.: 05350V106 CUSIP No. 05350V106 SCHEDULE 13G/A Page 5 of 8 Pages

If

Item 3.If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (a) Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o); (b) Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c); (c) Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c); (d) Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8); (e) x An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E); (f) An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F); (g) x A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G); (h) A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) A non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J); (k) A group, in accordance with 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J), please specify the type of institution: CUSIP No. 05350V106 SCHEDULE 13G/A Page 6 of 8 Pages Item 4.Ownership The information as of the filing date required by Items 4(a)-(c) is set forth in Rows 5-11 of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person. Item 5.Ownership of Five Percent or Less of a Class If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [X]. Item 6.Ownership of More Than Five Percent on Behalf of Another Person Not Applicable. Item 7. Identification and Classification of the Subsidiary which A

View Full Filing

View this SC 13G/A filing on SEC EDGAR